Sh2d1a-KO 基因敲除小鼠

1. Xiang, Qian-Ming, Jiang, Ni, Liu, Yue-Feng, Guo, Qiang, Li, Kai. 2023. Overexpression of SH2D1A promotes cancer progression and is associated with immune cell infiltration in hepatocellular carcinoma via bioinformatics and in vitro study. In BMC cancer, 23, 1005. doi:10.1186/s12885-023-11315-1. https://pubmed.ncbi.nlm.nih.gov/37858067/

2. Sumazaki, R, Kanegane, H, Osaki, M, Matsui, A, Miyawaki, T. . SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses. In Blood, 98, 1268-70. doi:. https://pubmed.ncbi.nlm.nih.gov/11493483/

3. Tangye, Stuart G. 2014. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. In Journal of clinical immunology, 34, 772-9. doi:10.1007/s10875-014-0083-7. https://pubmed.ncbi.nlm.nih.gov/25085526/

4. Sheth, Jayesh, Patel, Akash, Shah, Raju, Trivedi, Sunil, Sheth, Frenny. 2019. Rare cause of Hemophagocytic Lymphohistiocytosis due to mutation in PRF1 and SH2D1A genes in two children - a case report with a review. In BMC pediatrics, 19, 73. doi:10.1186/s12887-019-1444-4. https://pubmed.ncbi.nlm.nih.gov/30849948/